35233 membres inscrits Accès abonné revues  Aide   Newsletter    Me connecter
Les Communiqués
 
 
     Nasdaq OMX
 
Rechercher dans le flux Nasdaq GlobeNewswire
Rechercher
VWR to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 10, 2015
Tue, 03 05 2016 21:00:00
RADNOR, Pa., May 3, 2016 -- VWR Corporation (NASDAQ: VWR ), the leading global independent provider of product and service solutions to laboratory and production customers, today announced that Manuel Brocke-Benz, President and CEO, will (...)
Prothena Reports First Quarter 2016 Financial Results and Provides R&D Update
Tue, 03 05 2016 20:05:00
  Net cash used in operating and investing activities was $25.4 million in the first quarter; strong quarter-end cash position of $474.3 million, including net proceeds of $128.6 million raised through January 2016 (...)
CORRECTING and REPLACING -- Apricus Biosciences to Host Live Webcast KOL Event on May 9th Addressing Vitaros® and Erectile Dysfunction Population
Tue, 03 05 2016 18:43:31
In a release issued under the same headline earlier today by Apricus Biosciences, Inc. (Nasdaq:APRI), please note that in the second line of the subhead of the release, " 2H 2016 "   should (...)
LIVANOVA PLC : FILING OF PRELIMINARY PROXY STATEMENT ON SCHEDULE 14A WITH THE US SECURITIES AND EXCHANGE COMMISSION
Tue, 03 05 2016 17:17:30
LivaNova PLC (the "Company") announces today that it has filed its preliminary proxy statement on Schedule 14A with the US Securities and Exchange Commission ("SEC").  The document is available for viewing on the SEC website (...)
GENFIT: FEES GRANTED TO THE STATUTORY AUDITORS
Tue, 03 05 2016 16:57:11
GENFIT: FEES GRANTED TO THE STATUTORY AUDITORS Lille (France), Cambridge (Massachusetts, United States), May 3 rd , 2016 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a biopharmaceutical company at the forefront of (...)
GENFIT : HONORAIRES VERSES AUX COMMISSAIRES AUX COMPTES
Tue, 03 05 2016 16:57:11
GENFIT : HONORAIRES VERSES AUX COMMISSAIRES AUX COMPTES Lille (France), Cambridge (Massachusetts, Etats-Unis), le 3 mai 2016 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société biopharmaceutique engagée dans la découverte et le (...)
Bavarian Nordic A/S - Articles of Association
Tue, 03 05 2016 15:30:00
Updated Articles of Association for Bavarian Nordic A/S. BavarianNordicArticlesofAssociation This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. (...)
Late-Breaking Study Provides Evidence to Support Beneficial Seven-Year Clinical Outcomes and Patient Satisfaction for 2-Level Prestige LP(TM) Cervical Disc Patients
Tue, 03 05 2016 14:00:00
Study Represents Longest Patient Follow-Up Data for U.S. 2-Level Cervical Disc Patients DUBLIN and CHICAGO - May 3, 2016 - Medtronic plc (NYSE: MDT) today announced results of seven-year follow-up data demonstrating (...)
DXS International plc : Statement re: Exercise of Warrants
Tue, 03 05 2016 13:30:00
DXS INTERNATIONAL PLC Exercise of Warrants The Board of DXS International Plc ("DXS" or the "Company"), the ISDX quoted developer and supplier of clinical decision support systems to Clinical Commissioning (...)
RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. AND ORGANIZATION OF THE BOARD
Tue, 03 05 2016 13:30:00
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 3 May 2016 at 4.30 p.m. RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. AND ORGANIZATION OF THE BOARD The Annual General Meeting of Biotie Therapies Corp. was held on 3 May (...)
LivaNova plc : LivaNova PLC Total Voting Rights and Share Capital
Tue, 03 05 2016 13:09:40
LONDON, May 03, 2016 (GLOBE NEWSWIRE) -- In accordance with Disclosure and Transparency Rule 5.6, LivaNova PLC (the "Company") hereby notifies the market that as at 30 April 2016, the Company's capital consists of 49,068,145 ordinary (...)
XBiotech Appoints Amgen Veteran Scott Whitehurst as Chief Financial Officer
Tue, 03 05 2016 12:00:00
AUSTIN, Texas, May 03, 2016 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT), developer of True Human(TM) therapeutic antibodies, announced the appointment of Scott Whitehurst as Chief Financial Officer, effective today. He will oversee the (...)
Invitation to presentation of first quarter results 2016
Tue, 03 05 2016 11:52:24
Navamedic ASA invites you to a presentation of the first quarter results for 2016 and status for the company. The presentation takes place at Hotel Continental, Stortingsgaten 24/26, 0117 Oslo, Wednesday 11 May. The presentation will start at (...)
Trading in Novo Nordisk shares by board members, executives and associated persons on 2 May 2016
Tue, 03 05 2016 11:39:00
Company announcement No 36 / 2016 This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they (...)
Minerva Neurosciences Reports First Quarter 2016 Financial Results and Business Updates
Tue, 03 05 2016 11:30:00
Positive top line results of trials with MIN-202 highlight first quarter Last patient visits completed in trials with MIN-101 and MIN-117;   data expected in second quarter WALTHAM, Mass., May (...)
Apricus Biosciences to Host Live Webcast KOL Event on May 9th Addressing Vitaros® and Erectile Dysfunction Population
Tue, 03 05 2016 11:01:00
Presentation Speaker will be Edward D. Kim, M.D., Professor, The University of Tennessee Graduate School of Medicine Vitaros U.S. NDA Re-Submission Remains on Schedule for 2H 2016 SAN DIEGO, May (...)
Apricus Biosciences to Announce Corporate Update and First Quarter 2016 Financial Results
Tue, 03 05 2016 11:00:00
SAN DIEGO, May 03, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the Company's first quarter 2016 financial (...)
Abiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year
Tue, 03 05 2016 11:00:00
- Total Year Revenue of $329.5 Million, Up 43% Over Prior Year DANVERS, Mass., May 03, 2016 (GLOBE NEWSWIRE) --  Abiomed, Inc.  (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported fourth (...)
Photocure ASA: Presentation of the first quarter 2016 results
Tue, 03 05 2016 10:41:55
Photocure will present its first quarter report on Tuesday 10 May 2016 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will be Kjetil Hestdal, President & CEO and Erik (...)
uniQure Appoints Paul Firuta as Chief Commercial Officer
Tue, 03 05 2016 09:01:00
Amsterdam, the Netherlands, May 3, 2016 - uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced the appointment of Paul Firuta as Chief Commercial Officer. Mr. Firuta, who held similar positions at NPS (...)
MPI - Process Started Regarding Change of Marketplace
Tue, 03 05 2016 08:36:36
Hoersholm, May 3 2016 - Medical Prognosis Institute A/S (MPI.CO) announces that the company has initiated a process for change of marketplace from Nasdaq Copenhagen First North to Nasdaq Stockholm First North. Motive for planned Change of (...)
Enzymatica insiders plan to subscribe for SEK 16 million in new issue
Tue, 03 05 2016 08:07:50
Enzymatica announces that insiders such as board members, senior executives and their family members plan to subscribe for shares in the ongoing new issue equivalent to an amount of at least SEK 16 million, which corresponds to 27 percent of the (...)
Valmet and Biochemtex to collaborate in developing technology for lignin derived biochemicals
Tue, 03 05 2016 08:00:00
Valmet Corporation's press release on May 3, 2016 at 11:00 a.m. EET Valmet and Biochemtex will start to cooperate in the field of conversion of lignin into biochemicals. The development project will combine and adapt LignoBoost and (...)
CellaVision AB: Interim report January-March 2016
Tue, 03 05 2016 06:20:00
Strong first quarter with good growth and high operating margin January 1-March 31, 2015   Net sales increased by 12 % to SEK 58.3 million (51.8). Operating profit was SEK 13.9 million (10.5). The operating (...)
PCI Biotech: First quarter 2016 report
Tue, 03 05 2016 06:01:00
Oslo, 3 May 2016 Please find attached the first quarter 2016 report for PCI Biotech Holding ASA. Highlights include: Completed dose escalation in the bile duct cancer study, with promising early signs of efficacy Initiated (...)
publicités
publicité
 
  KauriWeb

Afficher toutes les thématiques